| Source HCPCS Code |
|
Target NDC Code |
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compound...
|
⇄
|
00093-4147-19
LEVALBUTEROL CONC 1.25 MG/0.5
|
| Detail Information |
| Relationship Start Date |
01/15/2018 |
| Relationship End Date |
09/30/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compound...
|
⇄
|
00093-4147-56
LEVALBUTEROL CONC 1.25 MG/0.5
|
| Detail Information |
| Relationship Start Date |
01/15/2018 |
| Relationship End Date |
09/30/2024 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compound...
|
⇄
|
00378-6993-31
LEVALBUTEROL CONC 1.25 MG/0
|
| Detail Information |
| Relationship Start Date |
08/28/2009 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7612
LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, 0.5 MG
|
⇄
|
00378-6993-93
LEVALBUTEROL (USP,PF) 1.25 MG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
08/28/2009 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
SOL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compound...
|
⇄
|
17478-0171-01
XOPENEX CONC 1.25 MG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
01/01/2005 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
UN |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7612
LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, 0.5 MG
|
⇄
|
17478-0171-30
XOPENEX (PF) 1.25 MG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
06/22/2015 |
| Relationship End Date |
02/23/2023 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
PC |
| Route Of Administration |
IH |
| Billing Units |
EA |
|
|
|
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compound...
|
⇄
|
17478-0173-24
XOPENEX 0.63 MG/3 ML SOLUTI
|
| Detail Information |
| Relationship Start Date |
08/20/2015 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
EA |
|
|
|
J7612
Levalbuterol, inhalation solution, fda-approved final product, non-compound...
|
⇄
|
17478-0174-24
XOPENEX 1.25 MG/3 ML SOLUTI
|
| Detail Information |
| Relationship Start Date |
08/20/2015 |
| Relationship End Date |
06/30/2023 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IH |
| Billing Units |
EA |
|
|
|
J7612
LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED,ADMINISTERED THROUGH D
|
⇄
|
27437-0056-01
XOPENEX HFA 45 MCG INHALER
|
| Detail Information |
| Relationship Start Date |
03/31/2007 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
GR |
| Ndc Package Type |
AER W/ADAP |
| Route Of Administration |
IH |
| Billing Units |
GM |
|
|
|
J7612
Levalbuteral, inhalation solution, fda-approved final product, non-compounded,...
|
⇄
|
63402-0510-01
XOPENEX HFA 45 MCG INHALER
|
| Detail Information |
| Relationship Start Date |
11/23/2005 |
| Relationship End Date |
10/02/2024 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
GR |
| Ndc Package Type |
AER W/ADAP |
| Route Of Administration |
IH |
| Billing Units |
GM |
|
|
|
J7612
LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, 0.5 MG
|
⇄
|
63402-0515-30
XOPENEX (PF) 1.25 MG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
4/1/2008 |
| Relationship End Date |
6/21/2015 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
PC |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
J7612
LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, CONCENTRATED FORM, 0.5 MG
|
⇄
|
65862-0942-03
LEVALBUTEROL (CONCENTRATE,PF) 1.25 MG/0.5 ML
|
| Detail Information |
| Relationship Start Date |
12/07/2017 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IH |
| Billing Units |
EA |
|
|
|
J7612
Levalbuterol non-comp con
|
⇄
|
00378-6993-93
Levalbuterol Inhalation Solution Concentrated
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|